WRN structural flexibility showcased through fragment-based lead discovery of inhibitors

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-025-66768-8
Affiliations:
8
Authors:
25
Go to article
Institutions Authors Share
Merck & Co, United States of America (USA)
22.000000
22.000000
22.000000
 0.88
Proteros Biostructures GmbH, Germany
2.000000
 0.08
Merck Sharp and Dohme Limited (MSD UK), United Kingdom (UK)
1.000000
 0.04
Interested in Oncology and Carcinogenesis?